Platelets: Physiology and Biochemistry^[*]

 

 Buy Article Permissions and Reprints

Abstract

This manuscript represents a republication of a manuscript originally published in STH in 2005. This republication is to help celebrate 50 years of publishing for STH. The original abstract follows.

Platelets are specialized blood cells that play central roles in physiologic and pathologic processes of hemostasis, inflammation, tumor metastasis, wound healing, and host defense. Activation of platelets is crucial for platelet function that includes a complex interplay of adhesion and signaling molecules. This article gives an overview of the activation processes involved in primary and secondary hemostasis, for example, platelet adhesion, platelet secretion, platelet aggregation, microvesicle formation, and clot retraction/stabilization. In addition, activated platelets are predominantly involved in cross-talk to other blood and vascular cells. Stimulated “sticky” platelets enable recruitment of leukocytes at sites of vascular injury under high shear conditions. Platelet-derived microparticles as well as soluble adhesion molecules, sP-selectin and sCD40L, shed from the surface of activated platelets, are capable of activating, in turn, leukocytes and endothelial cells. This article focuses further on the new view of receptor-mediated thrombin generation of human platelets, necessary for the formation of a stable platelet–fibrin clot during secondary hemostasis. Finally, special emphasis is placed on important stimulatory and inhibitory signaling pathways that modulate platelet function.

^* This article is a republished version of: Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005;31(04):381–392.

Publication History

Article published online:
12 December 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2003; 2 (01) 15-28
  CrossrefPubMedGoogle Scholar
• 2 Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol 1994; 6 (05) 695-704
  CrossrefPubMedGoogle Scholar
• 3 Fox JE. The platelet cytoskeleton. Thromb Haemost 1993; 70 (06) 884-893
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Clemetson KJ, Clemetson JM. Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology. Semin Thromb Hemost 1995; 21 (02) 130-136
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Jurk K, Clemetson KJ, de Groot PG. et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 2003; 17 (11) 1490-1492
  CrossrefPubMedGoogle Scholar
• 6 Frenette PS, Denis CV, Weiss L. et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191 (08) 1413-1422
  CrossrefPubMedGoogle Scholar
• 7 Romo GM, Dong JF, Schade AJ. et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999; 190 (06) 803-814
  CrossrefPubMedGoogle Scholar
• 8 Kehrel B. Platelet-collagen interactions. Semin Thromb Hemost 1995; 21 (02) 123-129
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Kehrel B, Balleisen L, Kokott R. et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71 (04) 1074-1078
  CrossrefPubMedGoogle Scholar
• 10 Polgár J, Clemetson JM, Kehrel BE. et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 1997; 272 (21) 13576-13583
  CrossrefPubMedGoogle Scholar
• 11 Kehrel B, Wierwille S, Clemetson KJ. et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 1998; 91 (02) 491-499
  CrossrefPubMedGoogle Scholar
• 12 Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274 (41) 29019-29024
  CrossrefPubMedGoogle Scholar
• 13 Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001; 12 (05) 261-273
  CrossrefPubMedGoogle Scholar
• 14 Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86 (01) 222-232
  PubMedGoogle Scholar
• 15 Fabre JE, Nguyen M, Latour A. et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999; 5 (10) 1199-1202
  CrossrefPubMedGoogle Scholar
• 16 Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004; 113 (03) 340-345
  CrossrefPubMedGoogle Scholar
• 17 Marcus AJ, Broekman MJ, Drosopoulos JH. et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99 (06) 1351-1360
  CrossrefPubMedGoogle Scholar
• 18 Dale GL, Friese P, Batar P. et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415 (6868) 175-179
  CrossrefPubMedGoogle Scholar
• 19 Nesbitt WS, Giuliano S, Kulkarni S, Dopheide SM, Harper IS, Jackson SP. Intercellular calcium communication regulates platelet aggregation and thrombus growth. J Cell Biol 2003; 160 (07) 1151-1161
  CrossrefPubMedGoogle Scholar
• 20 Kehrel B, Flicker E, Wigbels B, Osterfeld M, van de Loo J, Lüscher EF. Thrombospondin measured in whole blood–an indicator of platelet activation. Blood Coagul Fibrinolysis 1996; 7 (02) 202-205
  CrossrefPubMedGoogle Scholar
• 21 Singbartl K, Forlow SB, Ley K. Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J 2001; 15 (13) 2337-2344
  CrossrefPubMedGoogle Scholar
• 22 Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001; 86 (01) 214-221
  Article in Thieme ConnectPubMedGoogle Scholar
• 23 Lüscher EF, Weber S. The formation of the haemostatic plug–a special case of platelet aggregation. An experiment and a survey of the literature. Thromb Haemost 1993; 70 (02) 234-237
  Article in Thieme ConnectPubMedGoogle Scholar
• 24 Phillips DR, Law D, Scarborough RM. Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions. Arch Pathol Lab Med 1998; 122 (09) 811-812
  PubMedGoogle Scholar
• 25 Payrastre B, Missy K, Trumel C, Bodin S, Plantavid M, Chap H. The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol 2000; 60 (08) 1069-1074
  CrossrefPubMedGoogle Scholar
• 26 Lahav J, Jurk K, Hess O. et al. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002; 100 (07) 2472-2478
  CrossrefPubMedGoogle Scholar
• 27 Morgenstern E, Kehrel BE, Matzdorff A. et al. How do platelets aggregate?. [abstract] Ann Hematol 2001; 80: 48
  PubMedGoogle Scholar
• 28 Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70 (01) 119-123
  Article in Thieme ConnectPubMedGoogle Scholar
• 29 Puccetti L, Pasqui AL, Pastorelli M. et al. Platelet hyperactivity after statin treatment discontinuation. Thromb Haemost 2003; 90 (03) 476-482
  PubMedGoogle Scholar
• 30 Falati S, Liu Q, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197 (11) 1585-1598
  CrossrefPubMedGoogle Scholar
• 31 Huo Y, Schober A, Forlow SB. et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9 (01) 61-67
  CrossrefPubMedGoogle Scholar
• 32 Esposito CJ, Popescu WM, Rinder HM, Schwartz JJ, Smith BR, Rinder CS. Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery. Thromb Haemost 2003; 90 (06) 1128-1134
  Article in Thieme ConnectPubMedGoogle Scholar
• 33 Hoffmeister KM, Josefsson EC, Isaac NA, Clausen H, Hartwig JH, Stossel TP. Glycosylation restores survival of chilled blood platelets. Science 2003; 301 (5639) 1531-1534
  CrossrefPubMedGoogle Scholar
• 34 Bouchard BA, Catcher CS, Thrash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1997; 272 (14) 9244-9251
  CrossrefPubMedGoogle Scholar
• 35 Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22 (09) 1381-1389
  CrossrefPubMedGoogle Scholar
• 36 Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89 (04) 1121-1132
  CrossrefPubMedGoogle Scholar
• 37 Dörmann D, Kardoeus J, Zimmermann RE, Kehrel B. Flow cytometric analysis of agonist-induced annexin V, factor Va and factor Xa binding to human platelets. Platelets 1998; 9 (3–4) 171-177
  CrossrefPubMedGoogle Scholar
• 38 Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264 (29) 17049-17057
  CrossrefPubMedGoogle Scholar
• 39 Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9 (04) 458-462
  CrossrefPubMedGoogle Scholar
• 40 Nesheim ME, Furmaniak-Kazmierczak E, Henin C, Côté G. On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb Haemost 1993; 70 (01) 80-86
  Article in Thieme ConnectPubMedGoogle Scholar
• 41 Bouchard BA, Tracy PB. Platelets, leukocytes, and coagulation. Curr Opin Hematol 2001; 8 (05) 263-269
  CrossrefPubMedGoogle Scholar
• 42 Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19 (01) 170-177
  CrossrefPubMedGoogle Scholar
• 43 Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99 (03) 542-547
  CrossrefPubMedGoogle Scholar
• 44 Scandura JM, Walsh PN. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa. Biochemistry 1996; 35 (27) 8903-8913
  CrossrefPubMedGoogle Scholar
• 45 Dörmann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96 (07) 2469-2478
  CrossrefPubMedGoogle Scholar
• 46 Brass LF. More pieces of the platelet activation puzzle slide into place. J Clin Invest 1999; 104 (12) 1663-1665
  CrossrefPubMedGoogle Scholar
• 47 Holme PA, Orvim U, Hamers MJ. et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17 (04) 646-653
  CrossrefPubMedGoogle Scholar
• 48 Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990; 29 (03) 623-632
  CrossrefPubMedGoogle Scholar
• 49 Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC. et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96 (10) 3534-3541
  CrossrefPubMedGoogle Scholar
• 50 Henn V, Slupsky JR, Gräfe M. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391 (6667) 591-594
  CrossrefPubMedGoogle Scholar
• 51 Hartwell DW, Mayadas TN, Berger G. et al. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol 1998; 143 (04) 1129-1141
  CrossrefPubMedGoogle Scholar
• 52 Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98 (04) 1047-1054
  CrossrefPubMedGoogle Scholar
• 53 Aukrust P, Müller F, Ueland T. et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100 (06) 614-620
  CrossrefPubMedGoogle Scholar
• 54 Hollenbaugh D, Mischel-Petty N, Edwards CP. et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182 (01) 33-40
  CrossrefPubMedGoogle Scholar
• 55 André P, Prasad KS, Denis CV. et al. CD40L stabilizes arterial thrombi by a beta3 integrin–dependent mechanism. Nat Med 2002; 8 (03) 247-252
  CrossrefPubMedGoogle Scholar
• 56 Brass LF. Thrombin and platelet activation. Chest 2003; 124 (03) 18S-25S
  CrossrefPubMedGoogle Scholar
• 57 Hollopeter G, Jantzen HM, Vincent D. et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409 (6817) 202-207
  CrossrefPubMedGoogle Scholar
• 58 Rao AK. Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci 1998; 316 (02) 69-76
  CrossrefPubMedGoogle Scholar
• 59 Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood 1993; 82 (02) 505-512
  CrossrefPubMedGoogle Scholar
• 60 Covic L, Misra M, Badar J, Singh C, Kuliopulos A. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat Med 2002; 8 (10) 1161-1165
  CrossrefPubMedGoogle Scholar
• 61 Yang J, Wu J, Kowalska MA. et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci U S A 2000; 97 (18) 9984-9989
  CrossrefPubMedGoogle Scholar
• 62 Clemetson KJ. Platelet activation: signal transduction via membrane receptors. Thromb Haemost 1995; 74 (01) 111-116
  Article in Thieme ConnectPubMedGoogle Scholar
• 63 Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001; 86 (01) 189-197
  Article in Thieme ConnectPubMedGoogle Scholar
• 64 Bodin S, Viala C, Ragab A, Payrastre B. A critical role of lipid rafts in the organization of a key FcgammaRIIa-mediated signaling pathway in human platelets. Thromb Haemost 2003; 89 (02) 318-330
  Article in Thieme ConnectPubMedGoogle Scholar
• 65 Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. EMBO J 1997; 16 (21) 6414-6425
  CrossrefPubMedGoogle Scholar
• 66 Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J Cell Biol 2003; 160 (05) 769-780
  CrossrefPubMedGoogle Scholar
• 67 Woodside DG, Obergfell A, Leng L. et al. Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains. Curr Biol 2001; 11 (22) 1799-1804
  CrossrefPubMedGoogle Scholar
• 68 Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest 1999; 103 (01) 5-9
  CrossrefPubMedGoogle Scholar
• 69 Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999; 163 (02) 682-688
  CrossrefPubMedGoogle Scholar
• 70 Geiger J. Inhibitors of platelet signal transduction as anti-aggregatory drugs. Expert Opin Investig Drugs 2001; 10 (05) 865-890
  CrossrefPubMedGoogle Scholar
• 71 Aszódi A, Pfeifer A, Ahmad M. et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 1999; 18 (01) 37-48
  CrossrefPubMedGoogle Scholar
• 72 Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62 (09) 1153-1161
  PubMedGoogle Scholar
• 73 Beumer S, IJsseldijk MJ, de Groot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. Blood 1994; 84 (11) 3724-3733
  CrossrefPubMedGoogle Scholar
• 74 Timpl R, Brown JC. The laminins. Matrix Biol 1994; 14 (04) 275-281
  CrossrefPubMedGoogle Scholar
• 75 Fernandez-Patron C, Martinez-Cuesta MA, Salas E. et al. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 1999; 82 (06) 1730-1735
  Article in Thieme ConnectPubMedGoogle Scholar
• 76 Galt SW, Lindemann S, Allen L. et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002; 90 (10) 1093-1099
  CrossrefPubMedGoogle Scholar
• 77 Bornstein P. Cell-matrix interactions: the view from the outside. Methods Cell Biol 2002; 69: 7-11
  CrossrefPubMedGoogle Scholar
• 78 Angelillo-Scherrer A, de Frutos P, Aparicio C. et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001; 7 (02) 215-221
  CrossrefPubMedGoogle Scholar
• 79 Moers A, Nieswandt B, Massberg S. et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 2003; 9 (11) 1418-1422
  CrossrefPubMedGoogle Scholar
• 80 Abi-Younes S, Si-Tahar M, Luster AD. The CC chemokines MDC and TARC induce platelet activation via CCR4. Thromb Res 2001; 101 (04) 279-289
  CrossrefPubMedGoogle Scholar
• 81 Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, Wells TN. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000; 96 (13) 4046-4054
  CrossrefPubMedGoogle Scholar
• 82 Kowalska MA, Ratajczak MZ, Majka M. et al. Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets. Blood 2000; 96 (01) 50-57
  CrossrefPubMedGoogle Scholar